These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 3421992)

  • 41. Monoamine oxidase activities in dissociated cell fractions from rat skeletal muscle.
    Lyles GA; Archer DR
    J Pharm Pharmacol; 1986 Apr; 38(4):288-93. PubMed ID: 2872293
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Problems with the measurement of monoamine oxidase A protein concentration in mitochondrial preparations. Revised molecular activities and implications for estimating ratios of MAO A:MAO B molecules from radiochemical assay data.
    Riley LA; Denney RM
    Biochem Pharmacol; 1991 Oct; 42(10):1953-9. PubMed ID: 1741773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Some properties of semicarbazide-sensitive amine oxidases.
    Callingham BA; Barrand MA
    J Neural Transm Suppl; 1987; 23():37-54. PubMed ID: 3295116
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 3-(p-hydroxyphenyl)propionic acid as a new fluorogenic reagent for amine oxidase assays.
    Matsumoto T; Furuta T; Nimura Y; Suzuki O
    Anal Biochem; 1984 Apr; 138(1):133-6. PubMed ID: 6428269
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Studies on the metabolism of dimethylnitrosamine in vitro by rat-liver preparations. II. Inhibition by substrates and inhibitors of monoamine oxidase.
    Lake BG; Harris RA; Collins MA; Cottrell RC; Phillips JC; Gangolli SD
    Xenobiotica; 1982 Sep; 12(9):567-79. PubMed ID: 6818776
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
    Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
    Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Allylamine-induced vascular toxicity in vitro: prevention by semicarbazide-sensitive amine oxidase inhibitors.
    Ramos K; Grossman SL; Cox LR
    Toxicol Appl Pharmacol; 1988 Aug; 95(1):61-71. PubMed ID: 2842890
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rat monoamine oxidase B expressed in Escherichia coli has a covalently-bound FAD.
    Hirashiki I; Ogata F; Ito A
    Biochem Mol Biol Int; 1995 Sep; 37(1):39-44. PubMed ID: 8653086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The enhanced daily excretion of urinary methylamine in rats treated with semicarbazide or hydralazine may be related to the inhibition of semicarbazide-sensitive amine oxidase activities.
    Lyles GA; McDougall SA
    J Pharm Pharmacol; 1989 Feb; 41(2):97-100. PubMed ID: 2568436
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects in-vitro of procarbazine metabolites on some amine oxidase activities in the rat.
    Holt A; Sharman DF; Callingham BA
    J Pharm Pharmacol; 1992 Jun; 44(6):494-9. PubMed ID: 1359074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Does FAD-dependent polyamine oxidase contribute to the metabolism of milacemide?
    Strolin Benedetti M; Cocchiara G; Colombo M; Dostert P
    J Neural Transm Suppl; 1990; 32():351-6. PubMed ID: 2128509
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucose handling in streptozotocin-induced diabetic rats is improved by tyramine but not by the amine oxidase inhibitor semicarbazide.
    Visentin V; Bour S; Boucher J; Prévot D; Valet P; Ordener C; Parini A; Carpéné C
    Eur J Pharmacol; 2005 Oct; 522(1-3):139-46. PubMed ID: 16202994
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
    J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Electrophoretic properties of mitochondrial monoamine oxidase in monkey liver].
    Obata T; Egashira T; Yamanaka Y
    Nihon Yakurigaku Zasshi; 1987 Jul; 90(1):23-31. PubMed ID: 3653801
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Some problems with the diamine oxidase (DAO) assay using putrescine as substrate in rat liver.
    Ignesti G; Banchelli G; Pirisino R; Raimondi L; Buffoni F
    Agents Actions; 1993 May; 39(1-2):6-12. PubMed ID: 8285142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Effects of oxygen and drugs on monoamine oxidase in the dog liver].
    Kimura K
    Nihon Yakurigaku Zasshi; 1983 Apr; 81(4):305-13. PubMed ID: 6884886
    [TBL] [Abstract][Full Text] [Related]  

  • 58. On the presence of a clorgyline resistant benzylamine oxidase activity in mouse kidney.
    Banchelli G; Buffoni F; Raimondi L
    Pharmacol Res Commun; 1988 Jun; 20(6):465-83. PubMed ID: 3138700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Age-related changes in monoamine oxidase and semicarbazide-sensitive amine oxidase activities of rat aorta.
    Cao Danh H; Strolin Benedetti M; Dostert P; Mousset A
    J Pharm Pharmacol; 1985 May; 37(5):354-7. PubMed ID: 2862248
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arginine-42 and threonine-45 are required for FAD incorporation and catalytic activity in human monoamine oxidase B.
    Kirksey TJ; Kwan SW; Abell CW
    Biochemistry; 1998 Sep; 37(35):12360-6. PubMed ID: 9724550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.